These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 23156300)

  • 1. [Pathology of ovarian cancer].
    Kaku T; Watanabe S; Ohishi Y
    Nihon Rinsho; 2012 Jun; 70 Suppl 4():512-6. PubMed ID: 23156300
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pathology of ovarian cancer].
    Kaku T; Ogawa S; Hirakawa T; Ohishi Y
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():471-5. PubMed ID: 15535290
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytopathology of ovarian lesions: the intraoperative approach.
    Jiménez-Ayala M; Jiménez-Ayala Portillo B
    Monogr Clin Cytol; 2011; 20():60-76. PubMed ID: 21160249
    [No Abstract]   [Full Text] [Related]  

  • 4. Prognostic analysis of ovarian cancer associated with endometriosis.
    Kumar S; Munkarah A; Arabi H; Bandyopadhyay S; Semaan A; Hayek K; Garg G; Morris R; Ali-Fehmi R
    Am J Obstet Gynecol; 2011 Jan; 204(1):63.e1-7. PubMed ID: 21074136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis.
    McCluggage WG
    Pathology; 2011 Aug; 43(5):420-32. PubMed ID: 21716157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2014 FIGO staging for ovarian, fallopian tube and peritoneal cancer.
    Mutch DG; Prat J
    Gynecol Oncol; 2014 Jun; 133(3):401-4. PubMed ID: 24878391
    [No Abstract]   [Full Text] [Related]  

  • 7. Histological classification of ovarian cancer.
    Kaku T; Ogawa S; Kawano Y; Ohishi Y; Kobayashi H; Hirakawa T; Nakano H
    Med Electron Microsc; 2003 Mar; 36(1):9-17. PubMed ID: 12658347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dualistic classification of epithelial ovarian cancer: Is it clinically relevant?].
    Devouassoux-Shisheboran M; Genestie C; Ray-Coquard I
    Bull Cancer; 2016 Mar; 103(3):252-8. PubMed ID: 26853278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cytology of ovarian epithelial tumors].
    Otsuki T; Yaegashi N
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():503-6. PubMed ID: 15535296
    [No Abstract]   [Full Text] [Related]  

  • 10. Miscellaneous types of surface epithelial neoplasms. The well-differentiated end of the morphologic spectrum of endometrioid, clear-cell, and Brenner tumors and mixed epithelioid tumors of low malignant potential of müllerian type.
    Kempson RL; Hendrickson MR
    Pathology (Phila); 1993; 1(2):335-65. PubMed ID: 9420923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B7-H4 overexpression in ovarian tumors.
    Tringler B; Liu W; Corral L; Torkko KC; Enomoto T; Davidson S; Lucia MS; Heinz DE; Papkoff J; Shroyer KR
    Gynecol Oncol; 2006 Jan; 100(1):44-52. PubMed ID: 16256178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pathological diagnosis of ovarian cancer].
    Yamabe H
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():507-10. PubMed ID: 15535297
    [No Abstract]   [Full Text] [Related]  

  • 13. The expression of six biomarkers in the four most common ovarian cancers: correlation with clinicopathological parameters.
    Lin CK; Chao TK; Yu CP; Yu MH; Jin JS
    APMIS; 2009 Mar; 117(3):162-75. PubMed ID: 19245589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recent advances on ovarian epithelial cancer: definition, subtypes and pathologic features].
    Guo DH; Zheng WX
    Zhonghua Bing Li Xue Za Zhi; 2013 Sep; 42(9):624-8. PubMed ID: 24314254
    [No Abstract]   [Full Text] [Related]  

  • 15. TTF-1 expression in primary ovarian epithelial neoplasia.
    Graham AD; Williams AR; Salter DM
    Histopathology; 2006 May; 48(6):764-5. PubMed ID: 16681695
    [No Abstract]   [Full Text] [Related]  

  • 16. Surface epithelial tumours of the ovary.
    Maheshwari V; Tyagi SP; Saxena K; Tyagi N; Sharma R; Aziz M; Hameed F
    Indian J Pathol Microbiol; 1994 Jan; 37(1):75-85. PubMed ID: 8088904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in tumor type in low-stage versus high-stage ovarian carcinomas.
    Köbel M; Kalloger SE; Huntsman DG; Santos JL; Swenerton KD; Seidman JD; Gilks CB;
    Int J Gynecol Pathol; 2010 May; 29(3):203-11. PubMed ID: 20407318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Survival of patients with ovarian cancer in the Ul'ianovsk Region, 1999-2005].
    Antoneeva II
    Vopr Onkol; 2007; 53(4):393-5. PubMed ID: 17969399
    [No Abstract]   [Full Text] [Related]  

  • 19. The prognostic significance of elongation factor eEF1A2 in ovarian cancer.
    Pinke DE; Kalloger SE; Francetic T; Huntsman DG; Lee JM
    Gynecol Oncol; 2008 Mar; 108(3):561-8. PubMed ID: 18164751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential diagnosis of mesothelial and ovarian cancer cells in ascites by immunocytochemistry using Ber-EP4 and calretinin.
    Sato S; Okamoto S; Ito K; Konno R; Yajima A
    Acta Cytol; 2000; 44(3):485-8. PubMed ID: 10834020
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.